De-Escalation Strategies for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma-Where Are We Now?
- PMID: 35621685
- PMCID: PMC9139371
- DOI: 10.3390/curroncol29050295
De-Escalation Strategies for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma-Where Are We Now?
Abstract
The prevalence of oropharyngeal squamous cell carcinoma has been increasing in North America due to human papillomavirus-associated disease. It is molecularly distinct and differs from other head and neck cancers due to the young population and high survival rate. The treatment regimens currently in place cause significant long-term toxicities. Studies have transitioned from mortality-based outcomes to patient-reported outcomes assessing quality of life. There are many completed and ongoing trials investigating alternative therapy regimens or de-escalation strategies to minimize the negative secondary effects while maintaining overall survival and disease-free survival. The goal of this review is to discuss the most recent advancements within the field while summarizing and reviewing the available evidence.
Keywords: de-escalation; human papillomavirus; oropharyngeal squamous cell carcinoma; transoral surgery.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Global Cancer Observatory . International Agency for Research on Cancer. World Health Organization; Geneva, Switzerland: 2020.
-
- Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E., Jiang B., Goodman M.T., Sibug-Saber M., Cozen W., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 2011;29:4294–4301. doi: 10.1200/JCO.2011.36.4596. - DOI - PMC - PubMed
-
- Cancer Facts & Figures 2022. [(accessed on 12 March 2022)]. Available online: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-....
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical